Viewing Study NCT02684032


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-01-13 @ 1:02 PM
Study NCT ID: NCT02684032
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2016-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Sponsor: Celcuity Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-06-14
Start Date Type: ACTUAL
Primary Completion Date: 2022-01-19
Primary Completion Date Type: ACTUAL
Completion Date: 2022-01-19
Completion Date Type: ACTUAL
First Submit Date: 2016-02-10
First Submit QC Date: None
Study First Post Date: 2016-02-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-25
Last Update Post Date: 2022-07-27
Last Update Post Date Type: ACTUAL